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Abstract
Objective—We hypothesized second trimester serum cortisol would be higher in spontaneous 
preterm births compared to provider-initiated (previously termed ‘medically indicated’) preterm 
births.
Study design—We used a nested case-control design with a sample of 993 women with live 
births. Cortisol was measured from serum samples collected as part of routine prenatal screening. 
We tested whether mean adjusted cortisol fold-change differed by gestational age at delivery or 
preterm birth subtype using multivariable linear regression.
Result—An inverse association between cortisol and gestational age category (trend p=0.09) was 
observed. Among deliveries prior to 37 weeks, the mean adjusted cortisol fold-change values were 
highest for preterm premature rupture of the membranes (1.10), followed by premature labor 
(1.03) and provider-initiated preterm birth (1.01), although they did not differ statistically.
Conclusion—Cortisol continues to be of interest as a marker of future preterm birth. 
Augmentation with additional biomarkers should be explored.
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Prematurity affects more than 1 in 10 babies born globally, and is the second leading cause 
of death in children under 5 years.1 For many years, researchers have examined a range of 
biomarkers collected in pregnancy that were hoped to reliably predict some of the variance 
in risk of preterm birth or elucidate underlying biologic pathways. Cortisol is a hormone that 
is critical in fetal development and organ maturation,2 and it is the end product of the 
hypothalamic pituitary adrenal (HPA) axis, and thus is stress responsive. Maternal cortisol 
levels during pregnancy have been studied in saliva, plasma and hair, and thus far have been 
inconsistently associated with premature delivery.3–7 In a recent study examining cortisol in 
hair in each trimester, gestational age at delivery was negatively associated with second 
trimester cortisol, but not first or third.4 Similar findings were reported previously by 
Sandman and colleagues, where cortisol levels at 15 weeks of gestation predicted preterm 
birth, but not cortisol measured at later time points.8 A study in 646 women did not find any 
association between plasma cortisol measured at 24-26 weeks and spontaneous preterm 
birth.5 Another study found a positive association between hair cortisol (collected at 
delivery) and gestational age at delivery; however, authors note that the late collection may 
have primarily measured the strong natural rise in cortisol at the end of pregnancy, obscuring 
associations.6 Some of the heterogeneity in findings may be due to the timing of sample 
collection. One hypothesis supporting increased sensitivity to cortisol in the second trimester 
is that the fetus is relatively protected from maternal psychobiologic environment in the first 
trimester due to low maternal blood flow to the placenta and a small placental volume.4,9 In 
the third trimester, the HPA axis displays diminished responsiveness to exogenous 
corticotropin releasing hormone (CRH) challenge,10 potentially due to significantly higher 
function of the cortisol metabolizer 11β-hydroxysteroid dehydrogenase type 2 (11βHSD2), 
or reduced capacity of the maternal adrenal cortex, which is already producing high levels of 
cortisol in the third trimestser.4,11,12 A review of 15 studies of cortisol and preterm birth 
concluded that the majority of studies with samples prior to 23 weeks of gestation found 
relationships between cortisol and preterm birth, while analyses of samples collected later in 
pregnancy were not as consistent.7
Another area not well documented is whether cortisol is associated with spontaneous versus 
provider-initiated preterm birth subtypes. Provider-initiated preterm birth (previously 
referred to as ‘indicated’), accounts for 30-35% of preterm births. It includes delivery due to 
maternal or fetal factors such as congenital anomalies, maternal medical conditions (e.g., 
preeclampsia), and, fetal growth restriction.13,14 Spontaneous preterm birth includes 
premature labor (with intact membranes), accounting for 40-45% of preterm births, and 
preterm premature rupture of the membranes (PPROM), which accounts for 25-30% of 
preterm births.
In many cases of both premature labor and PPROM, inflammation or infection is believed to 
be involved in the underlying pathologic process.13,15–17 Inflammatory activation occurs 
during healthy parturition. Preterm labor, however, frequently entails early activation of 
these same processes, often on a larger scale, which at times may result from the bodies 
response to infection.17–19 Further, there are bi-directional associations between cortisol and 
inflammation. Pro-inflammatory cytokines IL-1β and TNF-α enhance production of 
placental CRH, a driver of cortisol, and down-regulate 11βHSD2,17 which could lead to 
higher cortisol levels. These and other inflammatory cytokines have been shown to be 
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elevated in asymptomatic women who went on to deliver preterm as early as 17-23 weeks of 
gestation,17,20 and have been described as key mediators of preterm labor.20 Asides from 
inflammation triggering increased cortisol, biobehavioral models of stress, infection and 
preterm birth have also postulated associations in the opposite direction. Wadhwa and 
colleagues hypothesized that maternal chronic stress, through cortisol, may modulate 
systemic and local immunity to increase susceptibility to intrauterine and fetal infections-
inflammatory processes. Among the direct mechanisms, this may occur through inhibition of 
production and response of lymphocytes to pro-inflammatory cytokines, and suppressing the 
differentiation of T-cells.18 Finally, further evidence for the association between stress and 
inflammatory cytokines was reported in the findings that elevated stress was related to IL-6, 
both in early and late pregnancy, and was also predictive of elevated IL-1β and IL-6 by 
stimulated lymphocytes in the 3rd trimester.19 Because of the bi-directional association 
between cortisol and inflammation/infection,21,22,19 we wanted to determine whether 
cortisol measured in the second trimester predicts the cause of a preterm delivery.
The frequency and morbidity associated with preterm deliveries warrants a continued 
research effort to identify early prenatal biomarkers that may signal a woman’s increased 
risk of any subtype of this outcome. Using a nested case-control design with a sample of 993 
live births in the state of California, we aimed to test two hypotheses. First, we hypothesized 
an inverse association between gestational age at delivery and second trimester serum 
cortisol levels. Second, among deliveries prior to 37 weeks, we hypothesized that due to 
unmeasured maternal stress, inflammation or infection, maternal serum cortisol would be the 
higher among spontaneous preterm births (both premature labor and PPROM) compared 
with provider-initiated preterm birth. Given the heterogeneity in causes of PPROM and 
premature labor, we chose to analyze these indications individually. Also, given the racial 
and ethnic disparities observed in both preterm birth23,24 and cortisol profiles,25 we further 
tested both of these aims taking into account race/ethnicity.
Methods
Source of the sample
From a cohort of 757,853 singleton live births in the state of California between 2009-2010, 
a nested case-control study of 993 live births was created. All women had a first trimester 
ultrasound and had a second trimester serum marker test done as part of routine prenatal 
screening for aneuploidies and neural tube defects done by the California Genetic Disease 
Screening Program (n = 241 000). Candidate cases and controls all had a record of a 15 to 
20 week second trimester serum sample that was banked by the California Biobank Program 
after it was used for routine screening (n = 77 604) and had detailed demographic and 
obstetric information in a linked hospital discharge birth cohort database maintained by the 
California Office of Statewide Health Planning and Development (OSHPD) (n = 61 339). A 
number of previous studies have leveraged data and screening results for women in this and 
other California cohorts.26,27 The final source set for this study included 4 025 singletons 
with births before 37 weeks, and 56 081 with births on or after 37 completed weeks through 
44 weeks. From this set, 500 terms births and 500 preterm births were selected with over-
sampling for births before 32 completed weeks gestation (n = 200). This sample included 
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196 women with deliveries before 32 weeks, 300 with deliveries between 32 and 36 weeks, 
and 497 with deliveries at or after 37 weeks, all with available serum samples. Serum 
samples for the remaining seven women were unavailable due to insufficient volume of 
sample or due to an inability to locate the specimen by the California Biobank Program.28 
Methods and protocols for the study were approved by the Committee for the Protection of 
Human Subjects within the Health and Human Services Agency of the State of California.
Cortisol
Sample metabolic profiling was performed by Metabolon, a commercial supplier of global 
metabolomic data.29 Samples were split into four extracts of approximately 25 ug; one for 
chromatography/mass spectrometry (LC/MS) in positive ionization mode, one for 
chromatography/mass spectrometry (LC/MS) in negative ionization mode, one for gas 
chromatography/mass spectrometry (GC/MS), and one aliquot was retained. LC/MS was 
performed on a Waters ACQUITY UPLC and a Thermo-Finnigan LTQ mass spectrometer, 
which consists of an electrospray ionization (ESI) source and linear ion-trap (LIT) mass 
analyzer. The sample extracts were analyzed under acidic positive and basic negative ion 
optimized conditions. Sample extracts designated for GC/MS analysis were analyzed on a 
Thermo-Finnigan Trace DSQ fast-scanning single-quadrupole mass spectrometer using 
electron impact ionization. Peaks were identified using Metabolon’s proprietary peak 
integration software. Compounds were identified by comparison to library entries of purified 
standards or recurrent unknown entities. Metabolon maintains a library based on 
authenticated standards that contains the retention time/index (RI), mass to charge ratio 
(m/z), and chromatographic data (including MS/MS spectral data) on all molecules present 
in the library. Data normalization was performed to correct variation resulting from 
instrument inter-day tuning differences.
In the data normalization process, a median normalization (to a value of 1.0) was performed 
to correct for variation from inter-day/inter-batch tuning differences. The fold change was 
calculated as the ratio of each observation scaled value to the median of 1.0. Cortisol values 
were slightly right (positive) skewed (skewness=0.93, Kurtosis=1.4, Shapiro-Wilk W=0.93, 
p<0.001). Transformation of the values by taking the square root reduced the right skew 
(skewness=0.24, Kurtosis=0.57, Shapiro-Wilk W=0.99, p<0.001). However, results were 
unchanged when estimated with the square root of the fold change; thus, for ease of 
interpretation, all results are shown as the untransformed values.
Gestational age at delivery, preterm birth subtype
Gestational age at delivery was categorized into <32 weeks (births at or prior to 32 weeks 0 
days) 32-36 weeks (births between 32 weeks 0 days and 36 weeks 6 days), 37-38 weeks 
(births at 37 weeks 0 days and 38 weeks 6 days), and >38 weeks (39 weeks 0 days and 
later). The first two categories are reflective of “very preterm birth” and “late preterm 
births.” Separating 37-38 weeks (“early term”) from >38 weeks accounts for the 
maturational heterogeneity that continues to occur through late gestation.30 For deliveries 
prior to 37 weeks, preterm birth subtype was defined as spontaneous preterm birth which 
included “premature labor” or “PPROM” analyzed separately, as coded in hospital discharge 
records by ICD-9 CM diagnosis. As described elsewhere,26 mothers delivering before 37 
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weeks receiving tocolytics based on hospital discharge records were also coded as having 
had a spontaneous preterm birth with premature labor. Preterm babies without a spontaneous 
preterm birth were considered to have a provider-initiated preterm birth if there was no 
spontaneous preterm birth and if there was a code for cesarean delivery or induction present 
in the hospital discharge file. If none of the codes for spontaneous or provider-initiated 
preterm birth were present in the hospital discharge files the baby was coded as having 
preterm birth with an unknown subtype.
Covariates
We relied on hypothesized causal models operationalized as directed acyclic graphs to select 
covariates a priori for multivariable adjustment from hospital discharge records and birth 
records. In final models, we included race/ethnicity, maternal pre-pregnancy weight, Medi-
Cal recipient status, and sex of the infant in models as potential confounders. Maternal pre-
pregnancy weight was missing in 30 samples (3%). We relied on single imputation by 
regressing weight on race/ethnicity, age, education and parity in order to calculate each 
woman’s predicted weight and used these values in instances of missing responses.
Statistical analyses
We first described the maternal and pregnancy characteristics by their frequency or mean 
values, both for the full sample and stratified by gestational age at delivery.
Gestational age at delivery and cortisol fold-change—To evaluate cortisol levels by 
gestational age category, we performed multivariable linear regression, with gestational age 
category as the predictor (with >38 weeks reference) and cortisol concentration as the 
outcome. We then abstracted the multivariable adjusted mean cortisol levels for each 
gestational age category from this model to present in a figure. Finally, we again performed 
multivariable linear regression with a continuous indicator variable for gestational age 
category to test for trend.
Gestational age at delivery and cortisol by race—To examine potential effect 
measure modification by race/ethnicity, the multivariable linear regression model was then 
stratified by each race/ethnicity, testing the association between gestational age category and 
cortisol level for each strata.
Preterm birth indication and cortisol fold-change—To estimate the association 
between cortisol and indication of preterm birth, we restricted the sample to those with 
deliveries prior to 37 weeks. We regressed cortisol on preterm birth subtype in multivariable 
linear regression, with provider-initiated deliveries serving as the reference group for 
PPROM and premature labor. Because very preterm birth (<32 weeks completed gestation) 
may have different underlying etiology than preterm deliveries between 32-36 weeks of 
gestation,26,31 we chose to further stratify the model by very preterm/preterm births.
Preterm birth indication and cortisol fold-change by race/ethnicity—To examine 
heterogeneity by race/ethnicity, we stratified the multivariable model by race/ethnicity, and 
again regressed cortisol level on the categorical indication for preterm birth variable, with 
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provider-initiated deliveries serving as the reference. We then abstracted each adjusted mean 
cortisol value for bar graphs in the figure.
All analyses were performed in SAS 9.4. A significance level of 0.05 was used for all 
analyses.
Results
Of the 991 births with complete data, 196 (19.8%) were delivered at less than 32 weeks of 
gestation, 300 (30.2%) were delivered between 32 and 36 weeks gestation, 165 (16.6%) 
were delivered between 37 and 38 weeks gestation, and 330 (33.3%) were delivered after 38 
weeks gestation (Table 1). On average, maternal serum samples were collected at 16.5 
weeks of gestation (range 15-20). Cortisol was not associated significantly with gestational 
age at sample collection (p=0.13). The median time lapse between second trimester serum 
collection and delivery was 20 weeks (range 4-26 weeks). Among births prior to 37 weeks, 
the median time lapse was 17 weeks (range 4-21 weeks).
Cortisol fold-change levels and gestational age
The multivariable adjusted mean cortisol value decreased with increasing categorical length 
of gestation (p for trend=0.09), however, in the full sample, the mean cortisol levels for each 
category of gestational length did not statistically differ from each other (Figure 1). When 
effects were stratified by race/ethnicity (Table 2), the same pattern of decreasing cortisol 
with increasing gestational age category was only observed among non-Hispanic White 
women. Among non-Hispanic White mothers, cortisol was significantly higher among 
women who gave birth at <32 weeks gestation relative to those who delivered after 38 weeks 
of gestation (standardized beta coefficient=0.14, 95% CI 0.01, 0.27). There were no other 
differences in cortisol levels by category of gestational age at delivery for any other race/
ethnicity groups.
Preterm birth subtype
In births prior to 37 weeks of gestation, cortisol fold-change values were generally highest 
for PPROM deliveries, followed by premature labor and provider-initiated preterm births; 
however, standardized beta coefficients did not statistically differ from the reference group 
(Table 3). When stratified by early (<32 weeks) and late (32-36 weeks) preterm birth, 
cortisol levels in provider-initiated deliveries were not statistically different than in the other 
two categories. Cortisol values by preterm birth subtypes for births prior to 37 weeks 
differed by race/ethnicity (Figure 2). Cortisol level in women with provider-initiated preterm 
births were significantly lower than those in women with PPROM in both non-Hispanic 
White and Black women, and significantly lower than Black women with premature labor. 
Cortisol did not differ by preterm birth subtype for any other race/ethnicity groups.
Discussion
Cortisol has been an inconsistent predictor of preterm birth in past research and our findings 
are no exception. We observed a marginally significant trend (p<0.10) for lower plasma 
cortisol with increasing gestational age, although the only statistically significant difference 
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was observed between the earliest and latest gestational age subgroups among non-Hispanic 
White women. When we limited births to deliveries prior to 37 weeks, cortisol levels 
appeared higher in both PPROM and premature labor indications compared to provider-
initiated deliveries; however, these differences were not statistically significant. In additional 
analyses stratified by race/ethnicity, cortisol levels were significantly higher in PPROM 
compared to provider-initiated deliveries among non-Hispanic White and Black women. 
This finding was not observed for Hispanics, Asians, or other race/ethnicities. Of note, 
exploratory analyses by race/ethnicity relied on small samples sizes, thus effect estimates 
may be unstable and would benefit from replication in larger samples.
The underlying causes of preterm delivery are assumed to be multifactorial.32 Our 
hypotheses that maternal cortisol levels may predict the timing of preterm birth and subtype 
relied on two rationales. First, premature labor may be an early activation of the normal 
labor process, which is influenced by fetal cortisol levels that stimulate a change in the 
progesterone/estrogen ratio at the time of parturition.13 Both maternal plasma and amniotic 
fluid cortisol have been shown to gradually increases from the 8th week of gestation to the 
36th week, with a steep rise through the onset of labor.33 Fetal cortisol concentrations of 
maternal origin are 10-fold lower than maternal levels, maintained through the expression of 
11βHSD2 in the placenta.34 However, elevated maternal plasma cortisol, which is further 
stimulated through the HPA axis by placental CRH, may lead to elevated cortisol exposure 
to the fetus, particularly in gestations with attenuated expression of 11βHSD2. Many factors 
have been associated with attenuated 11βHSD2 activity in humans and animal models, 
including stress, nutritional factors, environmental exposures, and elevated cortisol itself.
35–38
 The resulting elevated fetal cortisol early in pregnancy may prematurely prompt 
mechanisms for parturition typically delayed until later in pregnancy. Our results showing an 
inverse marginal effect of maternal cortisol concentration with increasing gestational age 
support this thinking. Additionally, the cortisol concentrations, which were collected at a 
standard time in pregnancy, were measured an average of 17 weeks prior to preterm 
deliveries, reducing the likelihood that we were observing cortisol spikes associated with 
imminent labor or delivery. Interestingly, our samples collected in the second trimester 
correspond with a reported “sensitive period” with respect to timing of cortisol elevation and 
preterm delivery; however, without measures at other time points, we could not formally test 
this hypothesis.
The second rationale informing our hypothesis concerned preterm birth subtype. Many risk 
factors for spontaneous preterm birth– both for premature labor and PPROM – result in 
inflammation in the form of maternal systemic or local infections, tobacco use, stress, and 
immune disorders.13 As previously discussed, there is bi-directional cross-talk between 
inflammatory markers and cortisol. We therefore hypothesized that cortisol would be higher 
among both types of spontaneous preterm births compared to provider-initiated preterm 
births. Our results in the full sample of births prior to 37 weeks, and among non-Hispanic 
White women and Black women, supported this hypothesis; however, we did not observe 
this pattern among women of other race/ethnicity groups. It should be noted, however, that 
we did not have complete information on the reasons for provider-initiated preterm delivery, 
which may have also been inflammatory in nature and would be expected to diminish the 
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contrast with spontaneous or PPROM deliveries. Thus, future studies might be able to obtain 
such information and fine tune these analyses.
The underlying rationale for assessing the role of cortisol and preterm birth in previous 
studies is due to a large literature reporting an association between prenatal anxiety, 
depression or stress and the increased risk of preterm birth (reviewed in 201539). However, 
cortisol may be elevated for other reasons than psychological stress, including inflammation, 
obesity, physical inactivity, age, smoking, alcohol intake, and medical conditions.40–42 Thus, 
while it is important to understand the contribution from stress and the intact HPA axis, we 
chose to focus only on cortisol as opposed to upstream psychosocial predictors. By 
evaluating cortisol as a biomarker, particularly as it relates to preterm birth subtypes, we 
may be able to identify women at risk of preterm birth, as well as generate additional 
hypotheses to test in relation to the underlying mechanisms.
Although many studies have attempted to characterize the role of cortisol in preterm 
delivery, our study has unique strengths that add to the literature. The nested case-control 
study design allowed for a sufficient sample of very premature deliveries for analysis, which 
enabled us to study the differences with late preterm births. Additionally, cortisol was 
obtained from non-targeted metabolomics, which allow for reliable identification of small 
molecule biomarkers. Further, this is one of the few studies that has considered the role of 
cortisol in the indication for preterm delivery, which aims to elucidate underlying 
mechanisms and provide a biomarker that can be considered in routine clinical care. Our 
findings must be considered in light of the limitations. Our serum samples were collected 
throughout the day as part of routine prenatal screening, and are subject to variability of the 
natural circadian rhythm. Although we do not expect systematic bias in the time of sample 
collection, the fluctuations based on the timing of sample collection may attenuate results. 
Additionally, our sample had very few Black women, who are 49% more likely to deliver 
preterm compared with all other women.43 We were unable to adequately characterize 
cortisol in this high-risk group, and strongly support further investigation with larger 
samples. Lastly, we would have benefited from measures of CRH and placental 11βHSD2 to 
inspect the interplay with cortisol, as well as repeated measures, which were not available as 
we relied upon second trimester banked serum.
Preterm birth and the sequelae of prematurity can have sizable adverse effects on future 
health. In searching for early predictors of preterm birth, researchers aim both to identify 
those at increased risk, and to understand underlying pathways of this multifactorial 
outcome. Our findings that support the role of cortisol as a biomarker for both timing and 
indication of delivery could be refined by models that incorporate in other biomarkers and 
multiple time points for trajectory analysis. Ultimately, the refinement of these predictive 
markers may allow for early identification and intervention of this intractable outcome.
Acknowledgments
This work was supported by NIH/NHLBI grants (RC2 HL101748, RO1 HD-57192, and R01 HD-52953), the Bill 
and Melinda Gates Millennium grants (OPP52256 and RSDP 5K12 HD-00849-23), March of Dimes grants (6-
FY11-261 and FY10-180) and the California Preterm Birth Initiative at the UCSF Benioff Children’s Hospital 
funded by Marc and Lynne Benioff. Data from the California Prenatal Screening Program was obtained through the 
California Biobank Program (Screening Information System request no. 476). Data were obtained with an 
Bandoli et al. Page 8
J Perinatol. Author manuscript; available in PMC 2018 November 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
agreement that the California Department of Public Health is not responsible for the results or conclusions drawn 
by the authors of this publication.
References
1. Howson CP, Kinney MV, McDougall L, Lawn JE. Born Toon Soon: Preterm birth matters. Reprod 
Health. 2013; 10:S1–S1. [PubMed: 24625113] 
2. Kapoor A, Dunn E, Kostaki A, Andrews MH, Matthews SG. Fetal programming of hypothalamo-
pituitary-adrenal function: Prenatal stress and glucocorticoids. J Physiol. 2006; 572:31–44. 
[PubMed: 16469780] 
3. Himes KP, Simhan HN. Plasma corticotropin-releasing hormone and cortisol concentrations and 
perceived stress among pregnant women with preterm and term birth. Am J Perinatol. 2011; 
28:443–448. [PubMed: 21136349] 
4. HOFFMAN MC, MAZZONI SE, WAGNER BD, LAUDENSLAGER ML, ROSS RG. Measures of 
Maternal Stress and Mood in Relation to Preterm Birth. Obstet Gynecol. 2016; 127:545–552. 
[PubMed: 26855101] 
5. Kramer MS, Lydon J, Goulet L, Kahn S, Dahhou M, Platt RW, et al. Maternal stress/distress, 
hormonal pathways and spontaneous preterm birth. Paediatr Perinat Epidemiol. 2013; 27:237–246. 
[PubMed: 23574411] 
6. Kramer MS, Lydon J, Seguin L, Goulet L, Kahn SR, McNamara H, et al. Stress pathways to 
spontaneous preterm birth: The role of stressors, psychological distress, and stress hormones. Am J 
Epidemiol. 2009; 169:1319–1326. [PubMed: 19363098] 
7. Giurgescu C. Are Maternal Cortisol Levels Related to Preterm Birth? J Obstet Gynecol Neonatal 
Nurs. 2009; 38:377–390.
8. Sandman CA, Glynn L, Schetter CD, Wadhwa P, Garite T, Chicz-DeMet A, et al. Elevated maternal 
cortisol early in pregnancy predicts third trimester levels of placental corticotropin releasing 
hormone (CRH): Priming the placental clock. Peptides. 2006; 27:1457–1463. [PubMed: 16309788] 
9. Burton GJ, Jaunaiux E. Maternal vascularisation of the human placenta: Does the embryo develop in 
a hypoxic environment? Gynecol Obstet Fertil. 2001; 29:503–508. [PubMed: 11575145] 
10. SCHULTE HM, WEISNER D, ALLOLIO B. the Corticotrophin Releasing Hormone Test in Late 
Pregnancy: Lack of Adrenocorticotrophin and Cortisol Response. Clin Endocrinol (Oxf). 1990; 
33:99–106. [PubMed: 2169361] 
11. Glover V. Maternal depression, anxiety and stress during pregnancy and child outcome; What 
needs to be done. Best Pract Res Clin Obstet Gynaecol. 2014; 28:25–35. [PubMed: 24090740] 
12. O’Donnell K, O’Connor TG, Glover V. Prenatal stress and neurodevelopment of the child: Focus 
on the HPA axis and role of the placenta. Dev Neurosci. 2009; 31:285–292. [PubMed: 19546565] 
13. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. 
Lancet. 2008; 371:75–84. [PubMed: 18177778] 
14. Reddy UM, Ko C-W, Raju TNK, Willinger M. Delivery indications at late-preterm gestations and 
infant mortality rates in the United States. Pediatrics. 2009; 124:234–40. [PubMed: 19564305] 
15. Xu Y, Romero R, Miller D, Silva P, Panaitescu B, Theis KR, et al. Innate lymphoid cells at the 
human maternal-fetal interface in spontaneous preterm labor. Am J Reprod Immunol. 
2018:e12820. [PubMed: 29457302] 
16. Romero R, Dey SK, Fisher SJ. Preterm labor: One syndrome, many causes. Science (80-). 2014; 
345:760–765.
17. Keelan JA. Intrauterine inflammatory activation, functional progesterone withdrawal, and the 
timing of term and preterm birth. J Reprod Immunol. 2018; 125:89–99. [PubMed: 29329080] 
18. Wadhwa PD, Culhane JF, Rauh V, Barve SS, Hogan V, Sandman CA, et al. Stress, infection and 
preterm birth: a biobehavioural perspective. Paediatr Perinat Epidemiol. 2001; 15:17–29. 
[PubMed: 11520397] 
19. Coussons-Read ME, Okun ML, Nettles CD. Psychosocial stress increases inflammatory markers 
and alters cytokine production across pregnancy. Brain Behav Immun. 2007; 21:343–350. 
[PubMed: 17029703] 
Bandoli et al. Page 9
J Perinatol. Author manuscript; available in PMC 2018 November 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
20. Vrachnis N, Karavolos S, Iliodromiti Z, Sifakis S, Siristatidis C, Mastorakos G, et al. Impact of 
mediators present in amniotic fluid on preterm labour. In Vivo (Brooklyn). 2012; 26:799–812.
21. DeSantis AS, DiezRoux AV, Hajat A, Aiello AE, Golden SH, Jenny NS, et al. Associations of 
salivary cortisol levels with inflammatory markers: The Multi-Ethnic Study of Atherosclerosis. 
Psychoneuroendocrinology. 2012; 37:1009–1018. [PubMed: 22178583] 
22. Yeager MP, Pioli PA, Guyre PM. Cortisol Exerts Bi-Phasic Regulation of Inflammation in Humans. 
Dose-Response. 2011; 9:332–347. [PubMed: 22013396] 
23. MENON R, DUNLOP AL, KRAMER MR, FORTUNATO SJ, HOGUE CJ. An overview of racial 
disparities in preterm birth rates: caused by infection or inflammatory response? Acta Obstet 
Gynecol Scand. 2011; 90:1325–1331. [PubMed: 21615712] 
24. Sanchez-Vaznaugh EV, Braveman PA, Egerter S, Marchi KS, Heck K, Curtis M. Latina Birth 
Outcomes in California: Not so Paradoxical. Matern Child Health J. 2016; 20:1849–1860. 
[PubMed: 27025385] 
25. Simon CD, Adam EK, Holl JL, Wolfe KA, Grobman WA, Borders AEB. Prenatal Stress and the 
Cortisol Awakening Response in African-American and Caucasian Women in the Third Trimester 
of Pregnancy. Matern Child Health J. 2016; 20:2142–2149. [PubMed: 27392704] 
26. Jelliffe-Pawlowski LL, Baer RJ, Blumenfeld YJ, Ryckman KK, O’Brodovich HM, Gould JB, et al. 
Maternal characteristics and mid-pregnancy serum biomarkers as risk factors for subtypes of 
preterm birth. BJOG. 2015; 122:1484–1493. [PubMed: 26111589] 
27. Wallenstein M, Jelliffe-Pawlowski LL, Yang W, Carmichael S, Stevenson D, Ryckman K, et al. 
Inflammatory biomarkers and spontaneous preterm birth among obese women. J Matern Fetal 
Neonatal Med. 2016; 29:3317–22. [PubMed: 26700828] 
28. Califonia Biobank Program. https://www.cdph.ca.gov/Programs/CFH/DGDS/Pages/cbp/
default.aspx
29. Ryckman KK, Jelliffe-pawlowski L, Bedell B, Holt T, Bell LN, Shaw GM, et al. Global Metabolic 
Profiling Implicates Altered Fatty Acid and Amino Acid Metabolism in Preterm Birth. 2017 
unpublished. 
30. Spong C. Defining ‘term’ pregnancy: Recommendations from the defining ‘term’ pregnancy 
workgroup. JAMA. 2013; 309:2445–2446. [PubMed: 23645117] 
31. Shapiro-Mendoza CK, Lackritz EM. Epidemiology of late and moderate preterm birth. Semin Fetal 
Neonatal Med. 2012; 17:120–125. [PubMed: 22264582] 
32. Behrman R, Butler A, editorsPreterm Birth: Causes, Consequences, and Prevention. Washington 
(DC): 2007. 
33. Chaim W, Mazor M. The relationship between hormones and human parturition. Arch Gynecol 
Obstet. 1998; 262:43–51. [PubMed: 9835999] 
34. Fowden AL, Forhead AJ, Coan PM, Burton GJ. The placenta and intrauterine programming. J 
Neuroendocrinol. 2008; 20:439–450. [PubMed: 18266944] 
35. Clarke KA, Ward JW, Forhead AJ, Giussani DA, Fowden AL. Regulation of 11 beta-
hydroxysteroid dehydrogenase type 2 activity in ovine placenta by fetal cortisol. J Endocrinol. 
2002; 172:527–34. [PubMed: 11874701] 
36. Seth S, Lewis AJ, Saffery R, Lappas M, Galbally M. Maternal Prenatal Mental Health and 
Placental 11β-HSD2 Gene Expression: Initial Findings from the Mercy Pregnancy and Emotional 
Wellbeing Study. Int J Mol Sci. 2015; 16:27482–27496. [PubMed: 26593902] 
37. Shang Y, Jia Y, Sun Q, Shi W, Li R, Wang S, et al. Sexually dimorphic effects of maternal dietary 
protein restriction on fetal growth and placental expression of 11β-HSD2 in the pig. Anim Reprod 
Sci. 2015; 160:40–48. [PubMed: 26205550] 
38. Mikelson C, Kovach MJ, Troisi J, Symes S, Adair D, Miller RK, et al. Placental 11β-
Hydroxysteroid dehydrogenase type 2 expression: Correlations with birth weight and placental 
metal concentrations. Placenta. 2015; 36:1212–1217. [PubMed: 26462907] 
39. Staneva A, Bogossian F, Pritchard M, Wittkowski A. The effects of maternal depression, anxiety, 
and perceived stress during pregnancy on preterm birth : A systematic review. Women and Birth. 
2015; 28:179–193. [PubMed: 25765470] 
Bandoli et al. Page 10
J Perinatol. Author manuscript; available in PMC 2018 November 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
40. Feller S, Vigl M, Bergmann MM, Boeing H, Kirschbaum C, Stalder T. Predictors of hair cortisol 
concentrations in older adults. Psychoneuroendocrinology. 2014; 39:132–140. [PubMed: 
24275012] 
41. Melin EO, Thunander M, Landin-Olsson M, Hillman M, Thulesius HO. Depression, smoking, 
physical inactivity and season independently associated with midnight salivary cortisol in type 1 
diabetes. BMC Endocr Disord. 2014; 14:75. [PubMed: 25224993] 
42. Incollingo Rodriguez AC, Epel ES, White ML, Standen EC, Seckl JR, Tomiyama AJ. 
Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: A systematic 
review. Psychoneuroendocrinology. 2015; 62:301–318. [PubMed: 26356039] 
43. Premature Birth Report Cards. March of Dimes. 2017; 2017:1–4.
Bandoli et al. Page 11
J Perinatol. Author manuscript; available in PMC 2018 November 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
Adjusted mean cortisol by gestational age at delivery. Models adjusted for race/ethnicity, 
maternal weight, Medi-Cal recipient, and sex of the infant.
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Figure 2. 
Adjusted mean cortisol levels by indication and race/ethnicity in births prior to 37 weeks of 
gestation. Models adjusted for maternal weight, Medi-Cal recipient, and sex of infant. 
Sample sizes reflective of complete case analysis. * indicates p<0.05.
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